FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327886475> ?p ?o ?g. }

• W4327886475 endingPage "927" @default.
• W4327886475 startingPage "913" @default.
• W4327886475 abstract "The prognostic significance of miR-107 and miR-17 in patients with acute myeloid leukemia (AML) remains unclear.A total of 173 patients with de novo AML from the Cancer Genome Atlas database were enrolled in this study and further divided into a chemotherapy group (98 cases) and an allogeneic hematopoietic stem cell transplantation (allo-HSCT) group (75 cases) according to their therapy regimen.In the chemotherapy cohort, high miR-107 or miR-17 expression was associated with poorer overall survival (OS) and event-free survival (EFS). On the other hand, there were no significant differences in OS and EFS between the high- and low-expression subgroups in the allo-HSCT group. Next, we stratified the total number of patients with AML into high- and low-expression groups according to the median expression levels of miR-107 or miR-17. In the high miR-107 or miR-17 expression group, patients treated with allo-HSCT had longer OS than those treated with chemotherapy. In the low miR-107 or miR-17 expression group, no significant differences in OS and EFS were observed between the two therapy subgroups. When patients were further clustered into three groups (both low miR-107 and low miR-17, either high miR-107 or high miR-17, and both high miR-107 and high miR-17), patients with both high miR-107 and high miR-17 expression had the worst OS and EFS of the entire group and of the chemotherapy group. On the other hand, there were no significant differences in OS and EFS among the three subgroups in the allo-HSCT group. Cox regression confirmed the concurrence of high expression of miR-107 and miR-17 might act as an independent prognostic factor for EFS and OS in the entire group and the chemotherapy group. Bioinformatics analysis showed differentially expressed genes (DEGs) associated with miR-107 and miR-17 expression were mainly enriched in multiple metabolic processes.The combination of miR-107 and miR-17 provides prognostic significance for patients with AML and should be considered in the clinical selection of the optimal treatment regimen when deciding between chemotherapy and allo-HSCT." @default.
• W4327886475 created "2023-03-21" @default.
• W4327886475 creator A5001937247 @default.
• W4327886475 creator A5020748598 @default.
• W4327886475 creator A5021293751 @default.
• W4327886475 creator A5027657298 @default.
• W4327886475 creator A5028404205 @default.
• W4327886475 creator A5039779053 @default.
• W4327886475 creator A5050909682 @default.
• W4327886475 date "2023-04-01" @default.
• W4327886475 modified "2023-10-18" @default.
• W4327886475 title "High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia" @default.
• W4327886475 cites W1967103142 @default.
• W4327886475 cites W1969955808 @default.
• W4327886475 cites W1975859778 @default.
• W4327886475 cites W1978826626 @default.
• W4327886475 cites W1992820945 @default.
• W4327886475 cites W2013130094 @default.
• W4327886475 cites W2025899661 @default.
• W4327886475 cites W2050931623 @default.
• W4327886475 cites W2084259236 @default.
• W4327886475 cites W2156486325 @default.
• W4327886475 cites W2159740826 @default.
• W4327886475 cites W2163337149 @default.
• W4327886475 cites W2184735178 @default.
• W4327886475 cites W2315640207 @default.
• W4327886475 cites W2336298858 @default.
• W4327886475 cites W2413561237 @default.
• W4327886475 cites W2503007795 @default.
• W4327886475 cites W2523562238 @default.
• W4327886475 cites W2608019907 @default.
• W4327886475 cites W2752053733 @default.
• W4327886475 cites W2767680586 @default.
• W4327886475 cites W2892197741 @default.
• W4327886475 cites W2900170869 @default.
• W4327886475 cites W2903429300 @default.
• W4327886475 cites W2907566492 @default.
• W4327886475 cites W2939140549 @default.
• W4327886475 cites W2941021863 @default.
• W4327886475 cites W2949917028 @default.
• W4327886475 cites W2959376013 @default.
• W4327886475 cites W2960708330 @default.
• W4327886475 cites W2989798489 @default.
• W4327886475 cites W2991538150 @default.
• W4327886475 cites W2999035723 @default.
• W4327886475 cites W3007335134 @default.
• W4327886475 cites W3008024249 @default.
• W4327886475 cites W3020864357 @default.
• W4327886475 cites W3044063803 @default.
• W4327886475 cites W3097444776 @default.
• W4327886475 cites W3158979938 @default.
• W4327886475 cites W3161313959 @default.
• W4327886475 cites W3165214482 @default.
• W4327886475 cites W3165461292 @default.
• W4327886475 cites W3180141556 @default.
• W4327886475 cites W3187909652 @default.
• W4327886475 cites W3202283796 @default.
• W4327886475 cites W3211798492 @default.
• W4327886475 cites W4206492422 @default.
• W4327886475 cites W4220702224 @default.
• W4327886475 cites W4221049844 @default.
• W4327886475 cites W4223425720 @default.
• W4327886475 cites W4225733922 @default.
• W4327886475 cites W4307554448 @default.
• W4327886475 cites W4309185544 @default.
• W4327886475 cites W4309772381 @default.
• W4327886475 cites W2969417115 @default.
• W4327886475 doi "https://doi.org/10.21037/tcr-22-2484" @default.
• W4327886475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37180663" @default.
• W4327886475 hasPublicationYear "2023" @default.
• W4327886475 type Work @default.
• W4327886475 citedByCount "2" @default.
• W4327886475 countsByYear W43278864752023 @default.
• W4327886475 crossrefType "journal-article" @default.
• W4327886475 hasAuthorship W4327886475A5001937247 @default.
• W4327886475 hasAuthorship W4327886475A5020748598 @default.
• W4327886475 hasAuthorship W4327886475A5021293751 @default.
• W4327886475 hasAuthorship W4327886475A5027657298 @default.
• W4327886475 hasAuthorship W4327886475A5028404205 @default.
• W4327886475 hasAuthorship W4327886475A5039779053 @default.
• W4327886475 hasAuthorship W4327886475A5050909682 @default.
• W4327886475 hasBestOaLocation W43278864751 @default.
• W4327886475 hasConcept C104317684 @default.
• W4327886475 hasConcept C126322002 @default.
• W4327886475 hasConcept C143998085 @default.
• W4327886475 hasConcept C145059251 @default.
• W4327886475 hasConcept C2776694085 @default.
• W4327886475 hasConcept C2777408962 @default.
• W4327886475 hasConcept C2778336483 @default.
• W4327886475 hasConcept C2778461978 @default.
• W4327886475 hasConcept C2778729363 @default.
• W4327886475 hasConcept C2911091166 @default.
• W4327886475 hasConcept C55493867 @default.
• W4327886475 hasConcept C71924100 @default.
• W4327886475 hasConcept C86803240 @default.
• W4327886475 hasConceptScore W4327886475C104317684 @default.
• W4327886475 hasConceptScore W4327886475C126322002 @default.
• W4327886475 hasConceptScore W4327886475C143998085 @default.

• next